NZ603672A - Process for preparing pyrimidinone compounds - Google Patents
Process for preparing pyrimidinone compoundsInfo
- Publication number
- NZ603672A NZ603672A NZ60367211A NZ60367211A NZ603672A NZ 603672 A NZ603672 A NZ 603672A NZ 60367211 A NZ60367211 A NZ 60367211A NZ 60367211 A NZ60367211 A NZ 60367211A NZ 603672 A NZ603672 A NZ 603672A
- Authority
- NZ
- New Zealand
- Prior art keywords
- formula
- compound
- treating
- thio
- heating
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- VTGOHKSTWXHQJK-UHFFFAOYSA-N pyrimidin-2-ol Chemical class OC1=NC=CC=N1 VTGOHKSTWXHQJK-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract 6
- -1 cyclopenta[d]pyrimidine compound Chemical class 0.000 abstract 4
- 238000010438 heat treatment Methods 0.000 abstract 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- 150000003335 secondary amines Chemical class 0.000 abstract 2
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 abstract 1
- 239000004471 Glycine Substances 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 abstract 1
- 239000003054 catalyst Substances 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 abstract 1
- 229910001385 heavy metal Inorganic materials 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- XLTUPERVRFLGLJ-UHFFFAOYSA-N isothiocyanato(trimethyl)silane Chemical compound C[Si](C)(C)N=C=S XLTUPERVRFLGLJ-UHFFFAOYSA-N 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 abstract 1
- DLFVBJFMPXGRIB-UHFFFAOYSA-N thioacetamide Natural products CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 abstract 1
- 150000003567 thiocyanates Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/04—Formation of amino groups in compounds containing carboxyl groups
- C07C227/06—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/04—Formation of amino groups in compounds containing carboxyl groups
- C07C227/06—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
- C07C227/08—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid by reaction of ammonia or amines with acids containing functional groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
- C07C229/16—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C229/48—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms of the same non-condensed ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34522410P | 2010-05-17 | 2010-05-17 | |
| PCT/US2011/036821 WO2011146494A1 (en) | 2010-05-17 | 2011-05-17 | Novel processes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ603672A true NZ603672A (en) | 2015-01-30 |
Family
ID=44992024
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ60367211A NZ603672A (en) | 2010-05-17 | 2011-05-17 | Process for preparing pyrimidinone compounds |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US9447052B2 (OSRAM) |
| EP (1) | EP2571857B1 (OSRAM) |
| JP (1) | JP6027529B2 (OSRAM) |
| KR (1) | KR20130089157A (OSRAM) |
| CN (2) | CN105837520A (OSRAM) |
| AR (1) | AR081399A1 (OSRAM) |
| AU (1) | AU2011256270B2 (OSRAM) |
| BR (1) | BR112012030532A2 (OSRAM) |
| CA (1) | CA2799520C (OSRAM) |
| CL (1) | CL2012003206A1 (OSRAM) |
| CO (1) | CO6630197A2 (OSRAM) |
| CR (1) | CR20120630A (OSRAM) |
| DO (1) | DOP2012000289A (OSRAM) |
| EA (1) | EA026569B1 (OSRAM) |
| IL (1) | IL223068A0 (OSRAM) |
| MA (1) | MA34301B1 (OSRAM) |
| MX (1) | MX2012013387A (OSRAM) |
| NZ (1) | NZ603672A (OSRAM) |
| PE (1) | PE20130318A1 (OSRAM) |
| PH (1) | PH12012502247A1 (OSRAM) |
| SG (1) | SG185559A1 (OSRAM) |
| TW (1) | TW201209043A (OSRAM) |
| UY (1) | UY33388A (OSRAM) |
| WO (1) | WO2011146494A1 (OSRAM) |
| ZA (1) | ZA201208631B (OSRAM) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201209043A (en) * | 2010-05-17 | 2012-03-01 | Glaxo Group Ltd | Novel processes |
| WO2015087239A1 (en) | 2013-12-11 | 2015-06-18 | Ranbaxy Laboratories Limited | Processes for the preparation of darapladib and its intermediates |
| WO2015092687A2 (en) | 2013-12-17 | 2015-06-25 | Ranbaxy Laboratories Limited | Process for the purification of darapladib |
| EP3687980B1 (en) | 2017-09-26 | 2022-01-19 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Radiolabeled darapladib, analogs thereof and their use as imaging compounds |
| US10866963B2 (en) * | 2017-12-28 | 2020-12-15 | Dropbox, Inc. | File system authentication |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1143516B (de) * | 1961-04-27 | 1963-02-14 | Bayer Ag | Verfahren zur Herstellung von Peptiden |
| US4277465A (en) | 1978-08-26 | 1981-07-07 | Kyoto Yakuhin Kogyo Kabushiki Kaisha | Adjuvant for promoting absorption of therapeutically active substances through the digestive tract |
| US4235776A (en) * | 1979-03-15 | 1980-11-25 | Eli Lilly And Company | Tetrahydro-2H-benzo[c]pyrroles |
| DE2941597A1 (de) * | 1979-10-13 | 1981-04-23 | Basf Ag, 6700 Ludwigshafen | Piperidinderivate von 4,5-dialkyl-3-hydroxy-pyrrol-2-carbonsaeureestern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen |
| US4619941A (en) * | 1984-11-19 | 1986-10-28 | American Cyanamid Company | N-[(1H-imidazol-1-yl)alkyl]-1H-indolecarboxamides useful as thromboxane synthetase inhibitors and antihypertensive agents |
| ES2203988T3 (es) | 1997-11-06 | 2004-04-16 | Smithkline Beecham Plc | Compuestos de pirimidinona y composiciones farmaceuticas que los contienen. |
| US6750228B1 (en) * | 1997-11-14 | 2004-06-15 | Pharmacia Corporation | Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| AU1520300A (en) | 1998-11-05 | 2000-05-29 | Biocryst Pharmaceuticals, Inc. | New cyclopentane and cyclopentene compounds and use for detecting influenza virus |
| US6953803B1 (en) * | 1999-05-01 | 2005-10-11 | Smithkline Beecham P.L.C. | Pyrimidine compounds |
| KR100781425B1 (ko) * | 2000-02-16 | 2007-12-03 | 스미스클라인비이참피이엘시이 | Ｌｄｌ-ｐｌａ2 억제제로서 피리미딘-4-온 유도체 |
| GB0119795D0 (en) | 2001-08-14 | 2001-10-03 | Smithkline Beecham Plc | Novel process |
| TW201209043A (en) * | 2010-05-17 | 2012-03-01 | Glaxo Group Ltd | Novel processes |
-
2011
- 2011-05-16 TW TW100117029A patent/TW201209043A/zh unknown
- 2011-05-16 AR ARP110101679 patent/AR081399A1/es unknown
- 2011-05-16 UY UY33388A patent/UY33388A/es not_active Application Discontinuation
- 2011-05-17 NZ NZ60367211A patent/NZ603672A/en not_active IP Right Cessation
- 2011-05-17 WO PCT/US2011/036821 patent/WO2011146494A1/en not_active Ceased
- 2011-05-17 CN CN201610182606.0A patent/CN105837520A/zh active Pending
- 2011-05-17 MX MX2012013387A patent/MX2012013387A/es unknown
- 2011-05-17 EP EP11784095.9A patent/EP2571857B1/en active Active
- 2011-05-17 CN CN201180035126.7A patent/CN103003249B/zh not_active Expired - Fee Related
- 2011-05-17 AU AU2011256270A patent/AU2011256270B2/en not_active Ceased
- 2011-05-17 PE PE2012002160A patent/PE20130318A1/es not_active Application Discontinuation
- 2011-05-17 BR BR112012030532A patent/BR112012030532A2/pt not_active IP Right Cessation
- 2011-05-17 SG SG2012083648A patent/SG185559A1/en unknown
- 2011-05-17 KR KR20127032795A patent/KR20130089157A/ko not_active Abandoned
- 2011-05-17 MA MA35441A patent/MA34301B1/fr unknown
- 2011-05-17 US US13/698,102 patent/US9447052B2/en not_active Expired - Fee Related
- 2011-05-17 JP JP2013511295A patent/JP6027529B2/ja not_active Expired - Fee Related
- 2011-05-17 CA CA2799520A patent/CA2799520C/en not_active Expired - Fee Related
- 2011-05-17 EA EA201291235A patent/EA026569B1/ru not_active IP Right Cessation
- 2011-05-17 PH PH1/2012/502247A patent/PH12012502247A1/en unknown
-
2012
- 2012-11-15 IL IL223068A patent/IL223068A0/en unknown
- 2012-11-15 DO DO2012000289A patent/DOP2012000289A/es unknown
- 2012-11-16 ZA ZA2012/08631A patent/ZA201208631B/en unknown
- 2012-11-16 CO CO12208170A patent/CO6630197A2/es unknown
- 2012-11-16 CL CL2012003206A patent/CL2012003206A1/es unknown
- 2012-12-12 CR CR20120630A patent/CR20120630A/es unknown
-
2016
- 2016-08-12 US US15/235,468 patent/US9725420B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ603672A (en) | Process for preparing pyrimidinone compounds | |
| MY144016A (en) | Process for the production of methyl (e)-2-{2-[6-(2-cyanophenoxy)pyrimidin-4-yloxy]phenyl}-3-methoxyacrylate | |
| MY147440A (en) | Process for making 3-substituted 2-amino-5-halobenzamides | |
| UA93424C2 (en) | Preparation of azoxystrobin | |
| NZ598643A (en) | Sustituted ( heteroarylmethyl ) thiohydantoins as anticancer drugs | |
| CL2016000346A1 (es) | Proceso para preparar compuestos intermediarios en la preparación de pirazolil pirrol pirimidinas. | |
| EA033468B1 (ru) | Способы получения конъюгата "антитело-майтансиноид" | |
| WO2008009963A3 (en) | Pyrimidine derivatives as modulators of parathyroid hormone receptors | |
| AR073073A1 (es) | Compuestos de pirrolo [ 2,3-d] pirimidina. | |
| DK2057126T3 (da) | Fremgangsmåde til fremstilling af 3-dihalomethyl-pyrazol-4-carboxylsyrederivater | |
| WO2010125216A3 (es) | Preparación de compuestos 5,6-dihidropirido[2,3-d]pirimidin-7(8h)-ona sustituidos | |
| AR072580A1 (es) | Procedimiento para la obtencion de esteres de acido pirazolcarboxilicos disustituidos en 1,3 | |
| NZ601805A (en) | Method for preparing tetrazole methanesulfonic acid salts, and novel compound used in same | |
| BRPI0407282A (pt) | Processo para preparação de inibidores de pirrolotriazina cinase | |
| UA107344C2 (uk) | Спосіб одержання 5-(2-{[6-(2,2-дифтор-2-фенілетокси)гексил]аміно}-1-гідроксіетил)-8-гідроксихінолін-2(1h)-ону | |
| WO2012111027A3 (en) | Process for pemetrexed disodium | |
| GEP20105099B (en) | Method for preparation of optionally 2-substituted 1,6- dihydrocarboxil acids | |
| JP2013530948A5 (OSRAM) | ||
| WO2012087888A3 (en) | Efficient peptide couplings and their use in the synthesis and isolation of a cyclopenta (g) quinazoline trisodium salt | |
| MX354498B (es) | Cristal de hidrato 5-hidroxi-1h-imidazol-4-carboxamida-3/4, metodo para producir el mismo y cristal de hidrato de 5-hidroxi-1h-imidazol-4-carboxamida. | |
| MX2012000431A (es) | Procedimientos para 3-amino-5-oxo-4,5-dihidro-[1,2,4]triazinas sustituidas. | |
| WO2013096819A3 (en) | Macromolecule positioning by electrical potential | |
| MY160308A (en) | Process for manufacturing 2-[(3,5-difluoro-3'-methoxy-1,1'-biphenyl-4-yl)amino]nicotinic acid | |
| ATE553098T1 (de) | Verfahren zur herstellung von rosuvastatin- calcium | |
| WO2011109675A3 (en) | Process for the preparation of 2-(cyclohexylmethyl)-n-{2- [(2s)-1-methylpyrrolidin-2-yl]ethyl}-1, 2, 3, 4- tetrahydroisoquinoline-7-sulfonamide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 17 MAY 2016 BY AJ PARK Effective date: 20150826 |
|
| LAPS | Patent lapsed |